|
|
Volumn 48, Issue 9, 2008, Pages 820-831
|
|
Cellular mechanisms of tumor response: Clinical demands;Zelluläre mechanismen der tumorresponse: Klinische anforderungen
|
|
Author keywords
RECIST (response evaluation criteria in solid tumors); Survival time; Targeted therapy; Therapy strategies; Tumor response
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
CETUXIMAB;
CYCLOPHOSPHAMIDE;
ENDOSTATIN;
ERLOTINIB;
ETOPOSIDE;
GEFITINIB;
IMATINIB;
METHOTREXATE;
PROTEIN TYROSINE KINASE;
SORAFENIB;
SUNITINIB;
TRASTUZUMAB;
VASCULOTROPIN RECEPTOR;
VINCRISTINE;
ADULT RESPIRATORY DISTRESS SYNDROME;
ALOPECIA;
ANOREXIA;
ANTIANGIOGENIC ACTIVITY;
APOPTOSIS;
BLEEDING;
BONE MARROW DISEASE;
BONE MARROW SUPPRESSION;
BRONCHOSPASM;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER THERAPY;
CELL ACTIVITY;
CELL DEATH;
CONJUNCTIVITIS;
CONSTIPATION;
DIAGNOSTIC IMAGING;
DIARRHEA;
DIGESTIVE SYSTEM PERFORATION;
DRUG TARGETING;
DYSPNEA;
FEVER;
GYNECOMASTIA;
HEART INFARCTION;
HUMAN;
HYPERSENSITIVITY REACTION;
HYPERTENSION ENCEPHALOPATHY;
HYPOMAGNESEMIA;
HYPOPHOSPHATEMIA;
HYPOTHYROIDISM;
INFECTION;
INFUSION REACTION;
INTERSTITIAL PNEUMONIA;
KERATOCONJUNCTIVITIS SICCA;
LEUKOENCEPHALOPATHY;
LEUKOPENIA;
MUSCLE CRAMP;
MUSCLE HYPERTONIA;
MYALGIA;
NEUROTOXICITY;
OUTCOME ASSESSMENT;
PARESTHESIA;
PNEUMONIA;
POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;
PROTEIN TARGETING;
RASH;
REVIEW;
STOMATITIS;
TACHYCARDIA;
THROMBOEMBOLISM;
TREATMENT INDICATION;
TREATMENT RESPONSE;
TUMOR VOLUME;
UNSPECIFIED SIDE EFFECT;
URINARY TRACT DISEASE;
VEIN THROMBOSIS;
COMPUTER SIMULATION;
DIAGNOSTIC IMAGING;
HUMANS;
MODELS, BIOLOGICAL;
NEOPLASMS;
OUTCOME ASSESSMENT (HEALTH CARE);
PROGNOSIS;
|
|
EID: 52549087786
PISSN: 0033832X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00117-008-1739-1 Document Type: Review |
|
Times cited : (3)
|
|
References (29)
|
